Adial Pharmaceuticals Faces Delisting Concerns
Ticker: ADIL · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: ADIL
TL;DR
ADIL might be delisted - big trouble for shareholders.
AI Summary
Adial Pharmaceuticals, Inc. filed an 8-K on March 7, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates a potential transfer of listing, with the earliest event reported on March 5, 2025. The company is incorporated in Delaware and its principal executive offices are located in Glen Allen, VA.
Why It Matters
This filing signals potential issues with Adial Pharmaceuticals' continued listing on an exchange, which could impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards indicates significant financial or operational distress for the company.
Key Players & Entities
- Adial Pharmaceuticals, Inc. (company) — Registrant
- March 5, 2025 (date) — Earliest event reported
- March 7, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Glen Allen, VA (location) — Address of principal executive offices
FAQ
What specific listing rule or standard has Adial Pharmaceuticals failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported is March 5, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on March 7, 2025.
Where are Adial Pharmaceuticals' principal executive offices located?
Adial Pharmaceuticals' principal executive offices are located at 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).